Brazil Wound Care Management Medical Equipment Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment

Brazil Wound Care Management Medical Equipment Industry Report: Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Advanced and Traditional Wound Management, Compression Therapy, Ostomy and Wound Closure Devices Medical Equipment

Brazil Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Brazil wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Brazil

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 14
2 Introduction 16
2.1 What Is This Report About? 16
2.2 Definitions 16
2.2.1 Wound Care Management 16
3 Healthcare Sector Review 18
3.1 Healthcare Expenditure 18
3.2 Healthcare Infrastructure 19
3.3 Healthcare Policy 19
4 Wound Care Management in Brazil 20
4.1 Wound Care Management Overall Revenues (2000-2012) 20
4.2 Wound Care Management Overall Volume (2000-2012) 26
4.3 Wound Care Management Overall Company Shares (2005-2006) 29
5 Wound Closure Devices in Brazil 30
5.1 Wound Closure Devices Overall Revenues (2000-2012) 30
5.1.1 Skin Closure Devices Overall Revenues (2000-2012) 34
5.1.2 Hemostats Overall Revenues (2000-2012) 36
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 38
5.2 Wound Closure Devices Overall Volume (2000-2012) 40
5.2.1 Skin Closure Devices Overall Volume (2000-2012) 42
5.2.2 Hemostats Overall Volume (2000-2012) 44
5.2.3 Tissue Sealants Overall Volume (2000-2012) 46
5.3 Wound Closure Devices Average Price (2000-2012) 48
5.3.1 Hemostats Average Price (2000-2012) 48
5.3.2 Tissue Sealants Average Price (2000-2012) 50
5.3.3 Skin Closure Devices Average Price (2000-2012) 52
5.4 Wound Closure Devices Distribution Share (2005-2006) 54
5.5 Wound Closure Devices Company Share (2005-2006) 55
6 Ostomy in Brazil 56
6.1 Ostomy Overall Revenue (2000-2012) 56
6.2 Ostomy Overall Volume (2000-2012) 58
6.3 Ostomy Average Price (2000-2012) 60
6.4 Ostomy Distribution Share (2005-2006) 62
6.5 Ostomy Company Share (2005-2006) 63
7 Advanced Wound Management in Brazil 64
7.1 Advanced Wound Management Overall Revenue (2000-2012) 64
7.2 Advanced Wound Management Overall Volume (2000-2012) 66
7.3 Advanced Wound Management Average Price (2000-2012) 68
7.4 Advanced Wound Management Distribution Share (2005-2006) 70
7.5 Advanced Wound Management Company Share (2005-2006) 71
8 Traditional Wound Management in Brazil 72
8.1 Traditional Wound Management Overall Revenue (2000-2012) 72
8.2 Traditional Wound Management Overall Volume (2000-2012) 74
8.3 Traditional Wound Management Average Price (2000-2012) 76
8.4 Traditional Wound Management Distribution Share (2005-2006) 78
8.5 Traditional Wound Management Company Share (2005-2006) 79
9 Compression Therapy in Brazil 80
9.1 Compression Therapy Overall Revenue (20000-2012) 80
9.2 Compression Therapy Overall Volume (2000-2012) 82
9.3 Compression Therapy Average Price (2000-2012) 84
9.4 Compression Therapy Distribution Share (2005-2006) 86
9.5 Compression Therapy Company Share (2005-2006) 87
10 Baxter International Company Profile 88
10.1 Company Overview 88
10.2 Business Overview 88
10.2.1 BioScience 88
10.2.2 Medication Delivery 88
10.2.3 Renal 89
10.2.4 Products 89
10.2.5 History 90
10.3 Value Chain Analysis 93
10.3.1 Manufacturing 93
10.3.2 Product Development 94
10.3.3 Sales and Marketing 94
10.4 SWOT Analysis 95
10.4.1 Baxter International Inc. Strengths 95
10.4.2 Baxter International Inc. Weaknesses 96
10.4.3 Baxter International Inc. Opportunities 96
10.4.4 Baxter International Inc. Threats 97
10.5 Financial and Operational Review 98
10.6 Locations And Subsidiaries 100
10.7 Financial Deals Landscape 102
10.7.1 Baiyunshan And Baxter Form A Joint Venture In China 102
10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration 103
10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital 105
10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter 107
10.7.5 Innovata signs a license agreement with Baxter International 108
10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International 110
10.7.7 Gambro Signs An Agreement With Baxter 111
10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement 113
10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System 115
10.7.10 Baxter International And Kaketsuken Enter Into Agreement 116
10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful 118
10.8 Recent Developments 119
10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007 119
10.8.2 Dec 18, 2007: Baxter Elects CFO 121
10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend 121
10.8.4 Aug 01, 2007: Baxter Elects New Board Director 121
10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend 122
10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization 122
10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend 122
10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend 123
10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America 123
10.9 Baxter International Inc. Pipeline Products 124
10.9.1 Next-Generation Home Hemodialysis Machine 124
11 Covidien Ltd./Tyco Healthcare Company Profile 126
11.1 Company Overview 126
11.2 Business Overview 126
11.2.1 Imaging Solutions 126
11.2.2 Medical Devices 127
11.2.3 Medical Supplies 127
11.2.4 Pharmaceutical Products 128
11.2.5 Retail Products 128
11.2.6 Products 129
11.2.7 History 130
11.3 Value Chain Analysis 131
11.3.1 Manufacturing 131
11.3.2 Product Development 131
11.3.3 Sales and Marketing 133
11.4 SWOT Analysis 133
11.4.1 Covidien Ltd./Tyco Healthcare Strengths 133
11.4.2 Covidien Ltd./Tyco Healthcare Weaknesses 134
11.4.3 Covidien Ltd./Tyco Healthcare Opportunities 135
11.4.4 Covidien Ltd./Tyco Healthcare Threats 136
11.5 Financial and Operational Review 137
11.5.1 Financial Statements 137
11.5.2 Financial Ratios 138
11.6 Locations And Subsidiaries 139
11.7 Financial Deals Landscape 141
11.7.1 Covidien Signs An Agreement With Allergan 141
11.7.2 Covidien Acquires Scandius Biomedical 142
11.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million 143
11.7.4 Covidien And BioSynthema Enter Into Licensing Agreement 145
11.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien 146
11.7.6 Covidien To Sell European Incontinence Business 148
11.7.7 Covidien To Acquire Tissue Science Laboratories 150
11.8 Recent Developments 152
11.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007 152
11.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend 152
11.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case 152
11.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results 152
11.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend 154
11.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results 154
11.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results 154
11.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent 157
11.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend 157
11.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results 157
11.9 Covidien Ltd./Tyco Healthcare Pipeline Products 159
11.9.1 PleuraSeal Lung Sealant System 159
11.9.2 Sandman Intro CPAP Device 160
12 3M Company Profile 162
12.1 Company Overview 162
12.2 Business Overview 162
12.2.1 Consumer and Office 162
12.2.2 Display and Graphics 162
12.2.3 Electro and Communications 163
12.2.4 Health Care 163
12.2.5 Industrial and Transportation 164
12.2.6 Safety, Security and Protection Services 165
12.2.7 Products 165
12.3 Value Chain Analysis 167
12.3.1 Manufacturing 168
12.3.2 Product Development 168
12.3.3 Sales and Marketing 168
12.4 SWOT Analysis 169
12.4.1 3M Company Strengths 169
3M Company Weaknesses 170
3M Company Opportunities 170
3M Company Threats 171
12.5 Financial and Operational Review 172
12.6 Locations And Subsidiaries 174
12.7 Financial Deals Landscape 176
12.7.1 3M Canada Acquires Les Entreprises Solumed 176
12.7.2 3M Acquires Bondo 178
12.7.3 3M Acquires Lingualcare 180
12.7.4 3M Acquires Abzil Industria E Comercio 182
12.7.5 3M Acquires Neo Plast 183
12.7.6 3M Acquires Assets Of DMS Chile 185
12.7.7 3M Acquires Business Of Innovative Paper Technologies 187
12.7.8 3M Acquires Powell 189
12.7.9 Gen-Probe Signs An Agreement With 3M Company 191
12.7.10 3M Acquires Acolyte Biomedica 194
12.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp. 196
12.7.12 3M Sells Its Pharmaceutical Business To Meda AB 198
12.7.13 3M Acquires SoftMed Systems 200
12.7.14 3M Sells its Pharmaceuticals Business to Graceway 202
12.7.15 Gen-Probe Signs An Agreement With 3M 204
12.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital 206
12.7.17 3M Acquires Biotrace International 208
12.7.18 Ekahau Secures $16 Million In Additional Funding 210
12.7.19 3M Acquires Brontes Technologies 213
12.7.20 3M acquires Nylonge Corp 215
12.7.21 3M Signs An Agreement With ClozeX Medical 217
12.7.22 3M Acquires OMNII Oral Pharmaceuticals 219
12.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway 221
12.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB 223
12.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital 226
12.7.26 3M Acquires Accuspray Application Technologies Inc. 229
12.7.27 3M to acquire Rochford Thompson Equipment 231
12.7.28 3M To Acquire Aearo Technologies From Permira 233
12.7.29 Permira To Sell Aearo Technologies To 3M 235
12.8 Recent Developments 238
12.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses 238
12.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State 238
12.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia 240
12.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia 240
12.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year 240
12.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend 240
12.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery 240
12.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend 240
12.8.9 May 08, 2007: 3M Declares Quarterly Dividend 241
12.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests 241
13 Ethicon, Inc. Company Profile 242
13.1 Company Overview 242
13.2 Business Overview 242
13.2.1 Products 243
13.3 Locations And Subsidiaries 244
13.4 Financial Deals Landscape 246
13.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON 246
13.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON 247
13.4.3 ETHICON Acquires Vascular Control Systems 249
13.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON 250
14 Coloplast A/S Company Profile 253
14.1 Company Overview 253
14.2 Business Overview 253
14.2.1 Medical Care 253
14.2.2 Major Products and Services 254
14.2.3 History 254
14.3 Value Chain Analysis 256
14.3.1 Manufacturing 256
14.3.2 Product Development 256
14.3.3 258
14.3.4 Sales and Marketing 258
14.4 SWOT Analysis 259
14.4.1 Coloplast A/S Strengths 259
14.4.2 Coloplast A/S Weaknesses 260
14.4.3 Coloplast A/S Opportunities 260
14.4.4 Coloplast A/S Threats 261
14.5 Financial and Operational Review 262
14.5.1 Financial Statements 262
14.5.2 Financial Ratios 263
14.5.3 Share Holding Structure 264
14.6 Locations And Subsidiaries 265
14.7 Financial Deals Landscape 267
14.7.1 Coloplast Sells Brachytherapy Business To Core Oncology 267
14.7.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies 268
14.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast’s Business Unit 270
14.7.4 McKesson Corporation Acquires Sterling Medical Services 271
14.7.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor 273
14.8 Recent Developments 275
14.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary 275
14.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results 275
14.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results 277
14.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results 279
14.8.5 May 15, 2007: Colplast Declares H1 2007 Results 280
14.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results 281
14.8.7 Dec 13, 2006: Coloplast Appoints New Chairman 283
14.8.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results 283
15 Regulation System 285
15.1 Medical Device Registration Protocol 285
15.1.1 Registration Documentation 285
15.1.2 Registration Procedure 286
15.1.3 Medical Device Registration Fee 287
16 Pricing and Reimbursement 288
17 Distribution Structure 289
18 APPENDIX 290
18.1 Global Markets Direct Research Methodology 290
18.2 Coverage 291
18.3 Secondary Research 291
18.4 Primary Research 292
18.5 Models 292
18.6 Forecasts 293
18.7 Expert Panels 293
18.8 Currency Conversion 294
18.9 Contact Us 295
18.10 Disclaimer 295



1.1 List of Tables
Table 1: Wound Care Management, Brazil, Overall Revenues ($ mn), 2000-2012 20
Table 2: Wound Care Management, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 21
Table 3: Wound Care Management, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 22
Table 4: Wound Care Management, Brazil, Category Revenues ($ mn), 2000-2012 23
Table 5: Wound Care Management, Brazil, Category Revenues ($ mn), Historic, 2000-2007 24
Table 6: Wound Care Management, Brazil, Category Revenues ($ mn), Forecast, 2007-2012 25
Table 7: Wound Care Management, Brazil, Category Volume (Units), 2000-2012 26
Table 8: Wound Care Management, Brazil, Category Volume (Units), Historic, 2000-2007 27
Table 9: Wound Care Management, Brazil, Category Volume (Units), Forecast, 2007-2012 28
Table 10: Wound Care Management, Brazil, Overall Company Share by Revenue ($ mn), 2005-2006 29
Table 11: Wound Closure Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 30
Table 12: Wound Closure Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 31
Table 13: Wound Closure Devices, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 32
Table 14: Wound Closure Devices, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012 33
Table 15: Skin Closure Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 34
Table 16: Skin Closure Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 35
Table 17: Hemostats, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 36
Table 18: Hemostats, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 37
Table 19: Tissue Sealants, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 38
Table 20: Tissue Sealants, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 39
Table 21: Wound Closure Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 40
Table 22: Wound Closure Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 41
Table 23: Skin Closure Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 42
Table 24: Skin Closure Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 43
Table 25: Hemostats, Brazil, Overall Volume (Units), Historic, 2000-2007 44
Table 26: Hemostats, Brazil, Overall Volume (Units), Forecast, 2007-2012 45
Table 27: Tissue Sealants, Brazil, Overall Volume (Units), Historic, 2000-2007 46
Table 28: Tissue Sealants, Brazil, Overall Volume (Units), Forecast, 2007-2012 47
Table 29: Hemostats, Brazil, Average Price ($), Historic, 2000-2007 48
Table 30: Hemostats, Brazil, Average Price ($), Forecast, 2007-2012 49
Table 31: Tissue Sealants, Brazil, Average Price ($), Historic, 2000-2007 50
Table 32: Tissue Sealants, Brazil, Average Price ($), Forecast, 2007-2012 51
Table 33: Skin Closure Devices, Brazil, Average Price ($), Historic, 2000-2007 52
Table 34: Skin Closure Devices, Brazil, Average Price ($), Forecast, 2007-2012 53
Table 35: Wound Closure Devices, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 54
Table 36: Wound Closure Devices, Brazil, Company Share by Revenue ($ mn), 2005-2006 55
Table 37: Ostomy, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 56
Table 38: Ostomy, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 57
Table 39: Ostomy, Brazil, Overall Volume (Units), Historic, 2000-2007 58
Table 40: Ostomy, Brazil, Overall Volume (Units), Forecast, 2007-2012 59
Table 41: Ostomy, Brazil, Average Price ($), Historic, 2000-2007 60
Table 42: Ostomy, Brazil, Average Price ($), Forecast, 2007-2012 61
Table 43: Ostomy, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 62
Table 44: Ostomy, Brazil, Company Share by Revenue ($ mn), 2005-2006 63
Table 45: Advanced Wound Management, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 64
Table 46: Advanced Wound Management, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 65
Table 47: Advanced Wound Management, Brazil, Overall Volume (Units), Historic, 2000-2007 66
Table 48: Advanced Wound Management, Brazil, Overall Volume (Units), Forecast, 2007-2012 67
Table 49: Advanced Wound Management, Brazil, Average Price ($), Historic, 2000-2007 68
Table 50: Advanced Wound Management, Brazil, Average Price ($), Forecast, 2007-2012 69
Table 51: Advanced Wound Management, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 70
Table 52: Advanced Wound Management, Brazil, Company Share by Revenue ($ mn), 2005-2006 71
Table 53: Traditional Wound Management, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 72
Table 54: Traditional Wound Management, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 73
Table 55: Traditional Wound Management, Brazil, Overall Volume (Units), Historic, 2000-2007 74
Table 56: Traditional Wound Management, Brazil, Overall Volume (Units), Forecast, 2007-2012 75
Table 57: Traditional Wound Management, Brazil, Average Price ($), Historic, 2000-2007 76
Table 58: Traditional Wound Management, Brazil, Average Price ($), Forecast, 2007-2012 77
Table 59: Traditional Wound Management, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 78
Table 60: Traditional Wound Management, Brazil, Company Share by Revenue ($ mn), 2005-2006 79
Table 61: Compression Therapy, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 80
Table 62: Compression Therapy, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 81
Table 63: Compression Therapy, Brazil, Overall Volume (Units), Historic, 2000-2007 82
Table 64: Compression Therapy, Brazil, Overall Volume (Units), Forecast, 2007-2012 83
Table 65: Compression Therapy, Brazil, Average Price ($), Historic, 2000-2007 84
Table 66: Compression Therapy, Brazil, Average Price ($), Forecast, 2007-2012 85
Table 67: Compression Therapy, Brazil, Distribution Share by Revenue ($ mn), 2005-2006 86
Table 68: Compression Therapy, Brazil, Company Share by Revenue ($ mn), 2005-2006 87
Table 69: Baxter International Inc., SWOT Analysis, 2006 95
Table 70: Baxter International Inc., Financial Statements, USD Million, 2002-2006 98
Table 71: Baxter International Inc., Financial Ratios, USD Million, 2002-2006 99
Table 72: Baxter International Inc., Other Locations 100
Table 73: Baxter International Inc., Subsidiaries 101
Table 74: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007 133
Table 75: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007 137
Table 76: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007 138
Table 77: Covidien Ltd./Tyco Healthcare, Other Locations 139
Table 78: Covidien Ltd./Tyco Healthcare, Subsidiaries 140
Table 79: 3M Company, SWOT Analysis, 2006 169
Table 80: 3M Company, Financial Statements, USD Million, 2002-2006 172
Table 81: 3M Company, Financial and Operational Overview, USD Million, 2002-2006 173
Table 82: 3M Company, Subsidiaries 175
Table 83: Ethicon, Inc., Other Locations 244
Table 84: Ethicon, Inc., Subsidiaries 245
Table 85: Coloplast A/S, SWOT Analysis , 2007 259
Table 86: Coloplast A/S, Financial Statements, DKK Million, 2003-2007 262
Table 87: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007 263
Table 88: Coloplast A/S, Share Holding Structure 264
Table 89: Coloplast A/S, Other Locations 265
Table 90: Coloplast A/S, Subsidiaries 265
Table 91: Coloplast A/S, Subsidiaries(Contd.) 266
Table 92: Medical Device Registration Fee in Brazil, 2002 287
Table 93: Currency Conversion from USD to Local Currency at 2007 Constant Rate 294



1.1 List of Figures
Figure 1: Health Expenditure by Source in Brazil, 1996 19
Figure 2: Wound Care Management, Brazil, Overall Revenues ($ mn), 2000-2012 20
Figure 3: Wound Care Management, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 21
Figure 4: Wound Care Management, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 22
Figure 5: Wound Care Management, Brazil, Category Revenues ($ mn), 2000-2012 23
Figure 6: Wound Care Management, Brazil, Category Revenues ($ mn), Historic, 2000-2007 24
Figure 7: Wound Care Management, Brazil, Category Revenues ($ mn), Forecast, 2007-2012 25
Figure 8: Wound Care Management, Brazil, Category Volume (Units), 2000-2012 26
Figure 9: Wound Care Management, Brazil, Category Volume (Units), Historic, 2000-2007 27
Figure 10: Wound Care Management, Brazil, Category Volume (Units), Forecast, 2007-2012 28
Figure 11: Wound Care Management, Brazil, Overall Company Share (%), 2006 29
Figure 12: Wound Closure Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 30
Figure 13: Wound Closure Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 31
Figure 14: Wound Closure Devices, Brazil, Revenue by Segment ($ mn), Historic, 2000-2007 32
Figure 15: Wound Closure Devices, Brazil, Revenue by Segment ($ mn), Forecast, 2007-2012 33
Figure 16: Skin Closure Devices, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 34
Figure 17: Skin Closure Devices, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 35
Figure 18: Hemostats, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 36
Figure 19: Hemostats, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 37
Figure 20: Tissue Sealants, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 38
Figure 21: Tissue Sealants, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 39
Figure 22: Wound Closure Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 40
Figure 23: Wound Closure Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 41
Figure 24: Skin Closure Devices, Brazil, Overall Volume (Units), Historic, 2000-2007 42
Figure 25: Skin Closure Devices, Brazil, Overall Volume (Units), Forecast, 2007-2012 43
Figure 26: Hemostats, Brazil, Overall Volume (Units), Historic, 2000-2007 44
Figure 27: Hemostats, Brazil, Overall Volume (Units), Forecast, 2007-2012 45
Figure 28: Tissue Sealants, Brazil, Overall Volume (Units), Historic, 2000-2007 46
Figure 29: Tissue Sealants, Brazil, Overall Volume (Units), Forecast, 2007-2012 47
Figure 30: Hemostats, Brazil, Average Price ($), Historic, 2000-2007 48
Figure 31: Hemostats, Brazil, Average Price ($), Forecast, 2007-2012 49
Figure 32: Tissue Sealants, Brazil, Average Price ($), Historic, 2000-2007 50
Figure 33: Tissue Sealants, Brazil, Average Price ($), Forecast, 2007-2012 51
Figure 34: Skin Closure Devices, Brazil, Average Price ($), Historic, 2000-2007 52
Figure 35: Skin Closure Devices, Brazil, Average Price ($), Forecast, 2007-2012 53
Figure 36: Wound Closure Devices, Brazil, Distribution Share (%), 2006 54
Figure 37: Wound Closure Devices, Brazil, Company Share (%), 2006 55
Figure 38: Ostomy, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 56
Figure 39: Ostomy, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 57
Figure 40: Ostomy, Brazil, Overall Volume (Units), Historic, 2000-2007 58
Figure 41: Ostomy, Brazil, Overall Volume (Units), Forecast, 2007-2012 59
Figure 42: Ostomy, Brazil, Average Price ($), Historic, 2000-2007 60
Figure 43: Ostomy, Brazil, Average Price ($), Forecast, 2007-2012 61
Figure 44: Ostomy, Brazil, Company Share (%), 2006 63
Figure 45: Advanced Wound Management, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 64
Figure 46: Advanced Wound Management, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 65
Figure 47: Advanced Wound Management, Brazil, Overall Volume (Units), Historic, 2000-2007 66
Figure 48: Advanced Wound Management, Brazil, Overall Volume (Units), Forecast, 2007-2012 67
Figure 49: Advanced Wound Management, Brazil, Average Price ($), Historic, 2000-2007 68
Figure 50: Advanced Wound Management, Brazil, Average Price ($), Forecast, 2007-2012 69
Figure 51: Advanced Wound Management, Brazil, Distribution Share (%), 2006 70
Figure 52: Advanced Wound Management, Brazil, Company Share (%), 2006 71
Figure 53: Traditional Wound Management, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 72
Figure 54: Traditional Wound Management, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 73
Figure 55: Traditional Wound Management, Brazil, Overall Volume (Units), Historic, 2000-2007 74
Figure 56: Traditional Wound Management, Brazil, Overall Volume (Units), Forecast, 2007-2012 75
Figure 57: Traditional Wound Management, Brazil, Average Price ($), Historic, 2000-2007 76
Figure 58: Traditional Wound Management, Brazil, Average Price ($), Forecast, 2007-2012 77
Figure 59: Traditional Wound Management, Brazil, Distribution Share (%), 2006 78
Figure 60: Traditional Wound Management, Brazil, Company Share (%), 2006 79
Figure 61: Compression Therapy, Brazil, Overall Revenues ($ mn), Historic, 2000-2007 80
Figure 62: Compression Therapy, Brazil, Overall Revenues ($ mn), Forecast, 2007-2012 81
Figure 63: Compression Therapy, Brazil, Overall Volume (Units), Historic, 2000-2007 82
Figure 64: Compression Therapy, Brazil, Overall Volume (Units), Forecast, 2007-2012 83
Figure 65: Compression Therapy, Brazil, Average Price ($), Historic, 2000-2007 84
Figure 66: Compression Therapy, Brazil, Average Price ($), Forecast, 2007-2012 85
Figure 67: Compression Therapy, Brazil, Distribution Share (%), 2006 86
Figure 68: Compression Therapy, Brazil, Company Share (%), 2006 87
Figure 69: Baxter International Inc., Value Chain Analysis 93
Figure 70: Covidien Ltd./Tyco Healthcare, Value Chain Analysis 131
Figure 71: 3M Company, Value Chain Analysis 167
Figure 72: Coloplast A/S, Value Chain Analysis 256
Figure 73: Global Markets Direct Methodology 290